Results 161 to 170 of about 39,777 (194)

Quinolones and Multidrug-Resistant Tuberculosis

Chemotherapy, 1999
The prevalence of initial resistance of multidrug-resistant tuberculosis (MDR-TB) to at least isoniazid (INH) and rifampicin (RFP) in Thailand during the period 1993–1997 is reported; in this era, trends for INH + RFP + streptomycin (SM) and ethambutol (EMB), INH + RFP + SM or EMB and MDR-TB were stable. The prevalence of acquired MDR-TB is on a slight
openaire   +2 more sources

▼Bedaquiline for multidrug-resistant tuberculosis

Drug and Therapeutics Bulletin, 2014
Resistance to drugs used to treat tuberculosis (TB) is a major public health problem that threatens progress made in TB management and control worldwide.1 It may result from improper use of antibiotics, including prescription of non-standard treatment regimens and poor adherence to drug therapy.
openaire   +2 more sources

Testicular tuberculosis in multidrug-resistant pulmonary tuberculosis

Journal of Infection and Chemotherapy, 2013
We report a rare case of multidrug-resistant pulmonary and testicular tuberculosis (TB) in a 25-year-old immunocompetent patient. The patient was suspected to have a testicular cancer. He underwent radical orchiectomy, and surgical pathology revealed a granuloma containing acid-fast bacilli in the testis.
Joo Wan, Seo, Chang Jun, Park, Tae Kyun, Kim, Jeong Ha, Mok, Mi Hyun, Kim, Kwangha, Lee, Ki Uk, Kim, Hye-Kyung, Park, Min Ki, Lee   +8 more
openaire   +2 more sources

Treatment of multidrug-resistant tuberculosis

Journal of Hospital Infection, 1995
Recent outbreaks of multi-drug-resistant tuberculosis (MDR-TB) have resulted in significant morbidity and mortality in patients with AIDS. The poor outcomes are attributable to delayed diagnoses, slow reporting of antimycobacterial susceptibility results, inadequate treatment regimens and profound immunosuppression.
openaire   +2 more sources

Multidrug-Resistant Tuberculosis

JAMA, 2005
DURING THE PAST DECADE MULTIDRUG-RESISTANT TUberculosis (MDR-TB) defined as resistance to at least isoniazid and rifampin has declined in the United States. The number of reported MDR-TB cases has decreased from 486 in 1993 to 114 in 2003 and the proportion of resistant strains of Mycobacterium tuberculosis has decreased by half.
openaire   +2 more sources

Multidrug resistant tuberculosis

Pathology, 2011
Multidrug resistant tuberculosis (MDRTB) and extensively resistant TB (XDRTB) are an increasing problem worldwide, especially in resource-poor nations. MDRTB is associated with vastly increased therapeutic costs and increased treatment failure rates.
openaire   +1 more source

[Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].

Kekkaku : [Tuberculosis], 1999
We studied the clinical characteristics, treatment and prognosis of multidrug-resistant pulmonary tuberculosis patients retrospectively. In this study, multidrug-resistant is defined as both resistant to 0.1 microgram/ml of INH and 50 micrograms/ml of RFP at least.
M, Ogawara, M, Sakatani
openaire   +1 more source

Multidrug Resistant Tuberculosis

MCN, The American Journal of Maternal/Child Nursing, 1993
openaire   +2 more sources

Clusters of Multidrug-Resistant Tuberculosis

Annals of Internal Medicine, 1993
B R, Edlin, S E, Valway, I M, Onorato
openaire   +2 more sources

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

Lancet, The, 2018
Erika Mohr, Sundari Mase, Zhiyi Lan
exaly